Methods for prevention or treatment of pruritus are provided. The methods comprise administering to a patient an effective amount of a kappa opioid receptor agonist compound. The involved kappa opioid receptor agonist compounds are of the type represented by the following formula III ##STR1##

• wherein R₁, R₂, Ar, X₇, and n are as defied in the specification.